Delivery Order SPE2DB20D1110-SPE2DB24FK53C

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $25,712.05 and is for the supply of Kerendia 10 mg tablets. The contract is a firm fixed price delivery order, with an ultimate completion date of September 22, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,970.95, is for the delivery of Kerendia 10 mg tablets. The contract has an ultimate completion date of November 13, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Kerendia 10 mg Tablet 90s. The one-year contract has a ceiling value of $1,142.66 and runs through November 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,108.44 award is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product, in support of military treatment programs. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA, with a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,712.13, is for the delivery of KERENDIA 10 MG TABLET 30S, a medical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the drug Kerendia 10 mg Tablet 30s, with a ceiling value of $3,377.11 and a completion date of October 23, 2024. The contract is a firm fixed-price delivery order with no set-aside requirements, indicating open competition. As a large IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 90 tablets of the drug Kerendia 10 mg, with a total ceiling value of $8,025.30. The contract is a firm fixed-price delivery order with an ultimate completion date of August 7, 2024. This order is not associated with any set-aside program. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,104.49 firm-fixed-price contract is for the supply of KERENDIA 10 MG TABLET 90S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $74,292.56 Firm Fixed Price Delivery Order contract is for the delivery of KERENDIA 10 MG TABLET 90S, a medication used to treat patients. The contract has a ceiling value of $74,292.56 and an ultimate completion date of November 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,158.94 contract is for the supply of the drug KERENDIA 10 MG TABLET 30S, with a period of performance through April 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB24FK53C
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets. The contract has a ceiling value of $2,967.23 and is a firm-fixed price agreement with a completion date of September 13, 2024. The award was made on September 12, 2024 and there is no set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide.

Generated 12/12/24, 10:13 AM